Judge Splits FTC's Endo Case, Scoffs At Transfer Threat
A Pennsylvania federal judge on Thursday split the Federal Trade Commission's suit accusing Endo and other drug companies of illegally delaying Opana ER and Lidoderm generics and challenged the government to...To view the full article, register now.
Already a subscriber? Click here to view full article